Patients with schizophrenia, whose current medication is not fully effective, will participate in a clinical trial to see if CBD is safe and effective when used alongside an anti-psychotic drug, according to a newly registered clinical trial.
At University of Colorado, approximately 60 people will participate in a clinical trial with hopes that CBD will relieve some of the troubling symptoms of Parkinson’s Disease.
Recruitment is underway for a clinical trial in Brazil to determine if CBD treatment can improve depressive and anxiety symptoms in individuals with bipolar disease.
A heart clinic in Mexico is planning a clinical trial led by a Professor of Medicine at Cornell University to determine safety of CBD in patients who’ve survived heart failure.
Large clinical trial – King’s College London – seeks to affirm CBD as a treatment for psychosis..
“CBD has emerged as a promising candidate as it displays anti-anxiety and anti-psychotic like properties in animals and humans.”
New research shows that an extra dose of CBD can help reduce side effects of regular cannabis use.